Dynavax: Analyzing Mixed Signals, Closer Look At Heplisav-B (NASDAQ:DVAX)

Multiple arrows pointing everywhere

PepeLaguarda/iStock via Getty Images

At a Glance

Building on my previous analysis of Dynavax Technologies (NASDAQ:DVAX), the landscape has shifted subtly. HEPLISAV-B sales continue to be a bright spot, but new elements like insider selling activities have entered the

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *